Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

2.4%

1 terminated/withdrawn out of 41 trials

Success Rate

96.3%

+9.8% vs industry average

Late-Stage Pipeline

41%

17 trials in Phase 3/4

Results Transparency

1 of 26 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

N/A

12(32.4%)

Phase 3

9(24.3%)

Phase 4

8(21.6%)

Phase 2

5(13.5%)

Phase 1

3(8.1%)

37Total

N/A(12)

Phase 3(9)

Phase 4(8)

Phase 2(5)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (41)

Showing 20 of 41 trials

NCT06378190Phase 1Recruiting

Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology

Role: collaborator

NCT06905834Phase 2Not Yet Recruiting

Evaluation of Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional Treatments

Role: collaborator

NCT04478721Phase 3Completed

Temocillin vs Meropenem for the Targeted Treatment of Bacteraemia Resistant to Third Gen Cephalosporins

Role: collaborator

NCT05210439Phase 4Active Not Recruiting

Efficacy and Safety of 7 Versus 14 Days of Antibiotic Treatment for Pseudomonas Aeruginosa Bacteraemia

Role: collaborator

NCT04037514Phase 3Completed

Paracetamol Versus Ibuprofen in Premature Infants With Hemodynamically Significant Patent Ductus Arteriosus

Role: collaborator

NCT05780073Phase 2Completed

Safety and Impact of Dasatinib on Viral Persistence and Inflammation in People With HIV Under Antiretroviral Treatment

Role: collaborator

NCT06423898Phase 4Recruiting

Ampicillin and Ceftriaxone for the Treatment of Enterococcus Faecalis Infective Endocarditis.

Role: collaborator

NCT05774236Phase 3Completed

Cook´s Balloon Versus Dinoprostone for Labor Induction of Term Pregnancies With Fetal Growth Restriction

Role: collaborator

NCT05086939Phase 3Active Not Recruiting

Multicenter Clinical Trial Comparing Treatment with Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control with Hyaluronic Acid in Patients with Knee Osteoarthritis.

Role: collaborator

NCT03225417Phase 1Active Not Recruiting

Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease.

Role: collaborator

NCT06513533Phase 2Recruiting

Dimethyl Fumarate in Adrenomyeloneuropathy

Role: collaborator

NCT03479138Completed

Non-Eosinophilic Neutrophilic Asthma

Role: collaborator

NCT03231657Not ApplicableCompleted

Randomizated Open-label Control Trial to Evaluate if the Incorporation of sFlt1/PlGF Ratio in the Diagnosis and Classification of PE Improves Maternal and Perinatal Outcomes in Women With the Suspicion of the Disease

Role: collaborator

NCT05394298Phase 4Unknown

Short vs Long of Usual Treatment for Non Complicated Enterococcal Bacteremia

Role: collaborator

NCT03371030Not ApplicableCompleted

Role of the Pronator Quadratus in Distal Radius Fractures

Role: collaborator

NCT03231787Not ApplicableCompleted

Clinical Trial in Antiaggregated Patients With Proximal Femur Fracture Evaluating a Strategy to Shorten Time Until Surgery

Role: collaborator

NCT03718273Phase 3Completed

IvaBRAdine blocK of Funny Current for Heart Rate Control in permanEnt Atrial Fibrillation. (BRAKE-AF Study).